1 / 54

PSYCHOPHARMACOLOGY REVIEW

PSYCHOPHARMACOLOGY REVIEW. Dr. Jan Banasch. Psychopharmacology Review. Anti-psychotics (including drugs to treat side effects) Mood stabilisers Antidepressants Anxiolytics . Objectives for Psychopharmacology Review. Distinguish the different classes of Anti-psychotics

shad-hansen
Télécharger la présentation

PSYCHOPHARMACOLOGY REVIEW

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. PSYCHOPHARMACOLOGY REVIEW Dr. Jan Banasch

  2. Psychopharmacology Review • Anti-psychotics (including drugs to treat side effects) • Mood stabilisers • Antidepressants • Anxiolytics

  3. Objectives for Psychopharmacology Review • Distinguish the different classes of Anti-psychotics • Recognize side effect profiles of Anti-psychotics and their management • Distinguish between the choices of mood stabilizers • Recognize side effects of mood stabilizers and the pathophysiology of Lithium excretion • To be able to select an appropriate antidepressant based on patient and drug choice profiles • Distinguish the side effects of antidepressants and their efficacy for indicated syndromes • Understand the differences between short and long-acting benzodiazepines • Recognize the indication for benzodiazepines

  4. Anti-Psychotics Two major classes Conventional vs Atypical Atypical – 1st line Wide indications for use • Psychosis • Mood stabilizer • Anxiolytic • Sleep

  5. Atypical Anti-Psychotics – 1st line ONLY Risperidone comes in a long-acting depot injection

  6. Conventional Anti-psychotics

  7. DePot (Long acting injections) May be given weekly, Q 2-3-4 weeks Compliance Issues/Treatment under the M.H.A.

  8. Atypical Anti-Psychotic Side Effects • Weight gain • Metabolic syndrome • Prolactinaemia • Agranulocytosis • Akathisia • Extrapyramidal symptoms

  9. Weight Gain • Clozapine/Olanzapine/Quetiapine – worst offenders • No weight gain with Aripiprazole or Ziprasidone (in fact weight loss)

  10. Metabolic Syndrome • Weight gain, ↑BMI • Diabetes Type II – Metformin • Hyperlipidemia – Statins • Hypertension - antihypertensives

  11. Prolactinaemia • Risperidone only • Dose dependent (levels ↑ as dose ↑ ) • Treat: Parlodel (Bromocriptine) • Gynaecomastia, erectile dysfunction • Amenorrhea

  12. Agranulocytosis • Clozapine only • Neutropenia – “Hypersensitivity Reaction?” • Special blood protocol

  13. Extrapyramidal Symptoms • Including dystonia – most common with Ziprasidone and with high doses of any atypical • Overall less common than with conventional anti-psychotics

  14. Akathisia • Most common with Aripiprazole (Abilify) ie starting dose is too high • Can be seen with other atypicals, usually at higher doses

  15. Atypical Anti-psychotic Induced Movement Disorders • Clozapine – No incidence • Risperidone – Akathisia, dystonia, EPS rarely TD • Olanzapine – Akathisia, dystonia, EPS • Quetiapine – Akathisia, especially restless legs • Ziprasidone – high risk of Akathisia, EPS and dystonia • Aripiprazole – high risk of Akathisia – increase very slowly • Overall incidence is much lower than with conventionals • Dose dependent • Ethnic vulnerability

  16. Conventional Anti-Psychotic Side Effects • Extrapyramidal symptoms • Akathisia • Dystonia • Tardive dyskinesia • Neuroleptic malignant syndrome

  17. Extrapyramidal Symptoms • Bradykinesia, mask like face, pill rolling tremor, cogwheeling rigidity, drooling, shuffling gait – Parkinsonism • Treat: Benztropine/anti-cholinergic

  18. Akathisia • Internal restlessness, insomnia, suicidality • “Ants in Pants” feeling • Treat: • Propranolol • Benzodiazepines - Lorazepam • Requip (tardive akathisia) • Not responsive to Benztropine

  19. Dystonia • Oral Buccal: • Tongue enlargement (risk of asphyxia) • Lock jaw • Torticollis – twisted neck • Occulogyric Crisis - “white of eyes” • Epistotonus – back arching • Treat: Urgently - IV/IM Benzotropine – fast resolution/reversible • Early warning sign of high risk to develop T.D.

  20. Tardive Dyskinesia • Oral Buccal – lip smacking, pouting, tongue protruding, bon-bon sign • Truncal – includes respiratory dyskinesia, diaphragmatic (belching, odd guttural utterances) • Can be extensive – choreiform movements of limbs/trunk • Very disabling – irreversible • Treat: Switch to Clozapine, antispasmodics, high dose Vit E

  21. Neuroleptic Malignant Syndrome (N.M.S.) • Clinical Features: • High fever > 40o C • Labile vital signs • Tachycardia • Muscle rigidity • Elevated creatinine kinase > 1,000 • Delirium • Incontinence • Treat: • Conservatively & symptomatically but IN hospital • Could use Dantrolene (as in malignant hyperthermia) • D/C all meds • Complications: • Renal Failure • Death

  22. Common Agents to Treat E.P.S.

  23. Common Agents to Treat Akathisia

  24. A Case of Worsening Psychosis or is it? • A patient presents to the Emergency Room in a state of mental disorganization. They have a history of schizophrenia. They are receiving anti-psychotic medications. • What is the differential diagnosis?

  25. Worsening Psychosis ?Non-compliance New medication Under medicated • Akathisia Restlessness→insomnia→worsening of psychotic symptoms 2° to irritability • Anticholinergic Delirium Took too many Cogentin either to treat side effects or to get ‘high’ 4.Neuroleptic Malignant Syndrome

  26. Mood Stabilizers • lst Line • Lithium Carbonate 300-1800 mg • Valproic Acid • Sodium Valproate (Epival) 500-2000 mg • Carbamazepine (Tegretol) 400-1200 mg • 2nd Line • Gabapentin (Neurontin) 300-1800 mg • Lamotrigine (Lamictal) 200 mg • Topiramate (Topamax) 100-200 mg Anti-Convulsant medications

  27. Mood Stabilizers • Atypical Anti-Psychotic • Have mood stabilizing properties • Monotherapy • Combined with mood stabilizer • Includes: • Clozapine Aripiprazole • Quetiapine Ziprasidone • Olanzapine Risperidone (consta im depot & oral) • Conventional Anti-Psychotics – as mood stabilizers • Clopixol LA depot im • Fluanxol depot im aids compliance

  28. Mood Stabilizers • Lithium Carbonate • Gold Standard since 1942 • Efficacy in acute mania of Bipolar 1 • Up to 80% full or partial responder • Up to 80% prevention of future episodes • Lessens intensity, severity, frequency of future episodes • Tolerability is variable • Dose range – 600-1500 mg/day (single dose qhs) • Abrupt cessation precipitates mania in 50% • Therapeutic range – 0.5-1.5 serum level • Decreases suicide rate significantly

  29. Side Effects of Lithium • Hypothyroidism (5-15%) • Gastric upset (20%) • Weight gain – water retention (30%) • Acne/psoriasis worsens • Leucocytosis • Renal Failure (↓GFR ↑Creat) – tubulointerstitial nephropathy • Cognitive dulling (↓memory, distractible) • Fatigue • Mild tremor • ECG – nonspecific (reversible) T wave changes (20-30%) • Nephrogenic diabetes insipidus (↓renal ability to concentrate urine)

  30. Predictors of Lithium Carbonate Failure • Non-compliance • Rapid cycling • Mixed states • Dysphoric mania • Substance abuse

  31. Serum Levels for Lithium Precipitants: Dehydration NSAIDS/Ibuprofen Sodium depleting diuretics (thiazides) Check levels 7 days after desired dose achieved 12 hrs after last dose

  32. Symptoms of Toxicity • Diarrhea Dysarthria • Tremor (coarse) Confusion • Abdominal pain Seizures • Ataxia Coma • Vomiting Death • Hold Lithium dose until symptoms abate • Drink fluids/restore hydration • Check levels serially • Hemodialysis (severe)

  33. Valproate/Valproic Acid • Effective for pure and mixed mania • Rapid cycling • Equal in efficacy to Lithium (80-90%) • Therapeutic level – 350-700 • Dose range – 1000-1500 mg/day

  34. Valproate Side Effects • Hair loss • Weight gain • Neurocognitive effects • Polycystic ovary disease • GERD/Reflux

  35. Carbamazepine • Effective in pure and mixed mania (70%) • Not very effective for rapid cycling • Hepatic enzyme induction • ADRS: Rash/Agranulocytosis • Therapeutic level =17-50 • Dose range – 600-1200 mg/day

  36. Teratogenesis of Mood Stabilizers • Lithium: • 1st Trimester – Ebsteins anomaly of heart (1 in 1-2000 vs 1 in 20,000) • Restart at 20/40 • No breast feeding • Anti-convulsants: • (Valproate, Carbamazepine, Gabapentin, Lamotrigine, Topiramate) • Neural tube defects

  37. Antidepressants • SSRIs: Selective Serotonergic Reuptake Inhibitors • SNRIs: Selective NorepinephrineReuptake Inhibitors • “Others” RIMA: Reuptake Inhibitor of Monamine • TCA: Tricyclic Antidepressants • MAOI: Monamine Oxidase 1st Line 2ND Line

  38. SSRIs CATIE Study – Zoloft and Celexa ranked most effective of all antidepressants (head:head trials)

  39. SSRIs – Side Effects • Sexual Dysfunction: Cialis/Viagra • anorgasmia • erectile dysfunction • ↓ libido • Weight Changes Switch A/D • Prozac – loss • Paxil – large gain • GI Upset Settles with time and dose related • nausea • diarrhea • Serotonergic Syndrome Stop A/D • much like akathisia Benzodiazepines • hyperstimulation Propanolol • jitteriness • agitation • “ants in your pants” • NOT SAFE TO USE IN BIPOLAR DEPRESSION

  40. SNRI • Selective Norepinephrine reuptake inhibitor • Dual Action 5HT/NE • Venlafaxine (Effexor/EffexorXR) 75-350 mg Depression/Anxiety • Duloxetine (Cymbalta) 40-60 mg Depression/Anxiety • Side Effects: Venlafaxine: • - sexual dysfunction (5HT) • - severe withdrawal syndrome (flu like) very gradual tapering, no abrupt discontinuation • Cymbalta: • - dry mouth, constipation, insomnia give in AM • NOT RECOMMENDED FOR USE IN BIPOLAR DEPRESSION (triggers mania)

  41. “Others”

  42. TCA (Also have muscarinic, histaminic and alpha adrenergic effects)

  43. TCA Side Effects • Anticholinergic: - dry mouth - constipation - blurred vision Do not use in BPH or glaucoma Cardiotoxic – fatal in O/D Seizure - ↓threshold Safer to use in Bipolar Depression

  44. MAOIs & RIMA • Inhibitors of Monoamine Oxidase – A (acts on 5HT and N/E, DA and Tyramine) • Phenelzine (Nardil) 15-90 mg • Tranylcypromine (Parnate) 20-90 mg • Isocarboxazid (Marplan) 10-50 mg • RIMA Reuptake inhibitor of monoamine oxidase - B (phenylethylamine/DA) • Moclobemide (Manerix) 150-600 mg • Indicated for Anxiety Disorders, Bipolar Depression Atypical/masked Depression/SADS Anxiety D/O Bulimia

  45. MAOI Side Effects • Hypertensive Crisis – triggered by diet • MAOI diet: • Low Tyramine – (avoid cheeses, processed meat, red wine, chocolate) • OTC, cough/cold preparations • Stimulants, sympathomimetics, meperidine • SSRIs, Wellbutrin, Remeron, SNRIs Leads to severe headache/hypertension with risk of death or stroke • Treat: IV Phentolamine • Patients must warn surgeons/dentists if having procedures • Need a two week wash-out period

  46. MAOI • May cause agitation, euphoria • May cause hypotension • Not safe to use in Bipolar Depression • RIMA – side effects • No need for low Tyramine diet • Safer to use in Bipolar Depression

  47. Anxiolytics • Indications: • Short term use • Treatment of generalized Anxiety Disorder • Adjunct treatment with antidepressants to cover the period before antidepressant becomes therapeutic • Akathisia • Hypnotic (short term, acute situations) • Alcohol withdrawal syndromes • Risks: • Addictive • Cognitive impairment • Disinhibition (Borderline Person D/o, Dementia) • Do not use in patients with sleep apnea (respiratory depression) • O/D risk when taken alone is low

  48. Benzodiazepines Commonly used as Anxiolytics

  49. Pharmacokinetics of Benzodiazepines • Rapidly absorbed from GI Tract • Poorly absorbed im (except Lorazepam) • Hepatic oxidation metabolic pathway (long acting) • Short acting benzodiazepines are metabolized by glucuronide conjugation – have no active metabolites • Short acting BZP – Lipophilic (rapid transfer across blood-brain barrier) • Long acting – subject to “build up” especially in elderly

More Related